Table 2.
ED and in-Hospital Stroke Code Activation Diagnostic Evaluation and Treatments.
| Emergency department stroke code activations | In-house stroke code activations | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Pre-Pandemic (n = 52) | Covid-19 Pandemic (n = 95) | P-value | Pre-Pandemic (n = 31) | Covid-19 Pandemic (n = 34) | P-value | |||||
| Final event diagnosis | 0.039 | 0.306 | ||||||||
| Vascular event, No. (%) | 26 | 50.0% | 64 | 67.4% | 9 | 29.0% | 14 | 41.2% | ||
| Mimic, No. (%) | 26 | 50.0% | 31 | 32.5% | 22 | 71.0% | 20 | 58.8% | ||
| Diagnostic imaging obtained | 0.212 | 0.009 | ||||||||
| None, No. (%) | 20 | 38.5% | 27 | 28.4% | 25 | 80.7% | 17 | 50.0% | ||
| Advanced vascular Imaging (CTA/P, MRA/P), No. (%) | 32 | 61.5% | 68 | 71.6% | 6 | 19.4% | 17 | 50.0% | ||
| Vascular Diagnosis | 0.884 | 0.498 | ||||||||
| Ischemic stroke, No. (%) | 14 | 26.9% | 34 | 35.8% | 6 | 19.4% | 11 | 32.4% | ||
| Intracerebral hemorrhage, No. (%) | 9 | 17.3% | 24 | 25.3% | 1 | 3.2% | 3 | 8.9% | ||
| TIA, No. (%) | 3 | 5.8% | 6 | 6.3% | 2 | 6.5% | 0 | 0% | ||
| t-PA administration, No. (%) | 4 | 7.7% | 7 | 7.4% | 1 | 0 | 0% | 0 | 0% | NA |
| Door to needle, median (IQR) | 36 | (36-40) | 47 | (40-82) | 0.112 | – | – | – | – | NA |
| Mechanical Thrombectomy, No. (%) | 3 | 5.8% | 7 | 7.4% | 1 | 0 | 0% | 2 | 5.9% | 0.493 |
| Door to puncture, median (IQR) | 125 | (111-137) | 207 | (149-286) | 0.031 | – | – | 123.5 | (120-127) | NA |
CTA: computed tomography angiogram; CTP: computed tomography perfusion; MRA: magnetic resonance angiography; MRP: magnetic resonance perfusion; TIA: transient ischemic attack; t-PA: tissue plasminogen activator.